权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Examining the Consequences of Reductions in Opioid Prescribing on Patients, Clinical Care, and Community Health

检查减少阿片类药物处方对患者、临床护理和社区健康的影响

基本信息

批准号：
9287748
负责人：
Kelly Ray Knight
金额：
$ 56.19万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-05-01 至 2022-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9287748
关键词：
Address Administrator Affect Alcohol or Other Drugs use American American Medical Association Area Caring Centers for Disease Control and Prevention (U.S.)Chronic Clinic Clinical Clinical Nursing Communities Community Health Complex Consult County Crime Criminal Justice Data Diagnosis Disclosure Drug Monitoring Drug Prescriptions Enrollment Environment Ethnography General Population Goals Health Health Personnel Heroin Home environment Human Resources Income Individual Interdisciplinary Study Interview Lead Longitudinal Studies Mediation Medicaid Medical Modeling Monitor Morbidity - disease rate Non-Malignant Opioid Pain Pain management Patient Monitoring Patients Physicians Policies Primary Health Care Public Health Qualitative Methods Qualitative Research Recommendation Recording of previous events Reporting Research Research Personnel Sampling San Francisco Social Impacts Social Problems Societies Source Withdrawal care delivery clinical care community setting disorder prevention end of life experience follow-up improved mortality non-cancer pain opioid misuse pain symptom patient population prescription opioid programs psychologic research study response safety net social

项目摘要

We propose to use qualitative methods to examine the consequences of reductions in opioid prescribing for chronic non-cancer pain (CNCP) on patients, clinical care delivery, and community health. Over 80 million Americans report CNCP, defined as non-malignant pain that lasts longer than three months, not associated with end of life. Escalations in opioid prescribing for CNCP over the past two decades have been associated with dramatic increases in opioid-associated morbidity and mortality. In response, the Centers for Disease Control and Prevention, the American Pain Society, and the American Medical Association developed recommendations to limit reliance on opioids, by encouraging clinicians to (1) consult statewide prescription drug monitoring programs when prescribing opioids; (2) not initiate opioid therapy for CNCP; and (3) monitor, taper, and/or discontinue opioids in CNCP patients. These recommendations are being implemented nationwide and evidence suggests a concomitant decrease in the total number of opioid prescriptions. Yet, little data exist documenting the long term consequences, positive or negative, of reductions in opioid prescribing. The proposed study builds on our previous R01 (DA034625), Pain Management in the Clinic and Community (PMCC), that examined the management of CNCP in patients with a history of substance use who received pain care in safety net clinical settings. Medicaid insured patients with a CNCP diagnosis are more likely than their privately insured counterparts with CNCP to receive opioid prescriptions. Patients with a history of substance use are more likely to receive a diagnosis of CNCP, to be prescribed opioids, and to transition to chronic opioid therapy than patients without substance use histories. The proposed study will use the social-ecological model of health to address the following specific aims: (SA1) To examine the consequences of reductions in opioid prescribing on patients' experiences of CNCP; (SA2) To examine the consequences of reductions in opioid prescribing on patient-clinician relationships and clinical care delivery in primary care safety net settings; (SA3) To examine the consequences of reductions in opioid prescribing from the perspectives of community stakeholders. The proposed longitudinal study will take place in four safety-net clinics and patients' home/community environments in two diverse San Francisco Bay Area Counties. We will conduct qualitative enrollment and follow-up interviews with 30 primary care clinicians and 60 of their CNCP patients with a history of substance use, and clinical observations between clinicians and matched patients (SA1&2). We will theoretically sample 30 of the 60 CNCP patients and conduct ethnography in patients' home environments, and interview 40 community stakeholders (SA1&3). The multidisciplinary research team, consisting of a medical anthropologist, a physician investigator who studies opioid misuse and practices in the safety net, and a nurse/clinical pain policy expert will synthesize the data with the goal of improving our understanding of the consequences of opioid prescription reductions to make clinical and policy recommendations.

我们建议使用定性方法来检查减少阿片类药物处方的后果